T he purpose of this article is to answer some of the many questions that arise from the administration and interpretation of tuberculin skin testing. It should be considered a guide for persons responsible for the administration and interpretation of such testing.
The tuberculin skin test is the traditional method used to demonstrate infection with Mycobacterium tuberculosis . It is less than 100% sensitive and specific for detection of M. tuberculosis infection; however, no better diagnostic method has been devised (American Thoracic Society/ Centers for Disease Control and Prevention, 1990) .
The intradermal (Mantoux) administration of 0.1 mL of Purified Protein Derivative (PPD) containing five test units into the flexor or dorsal surface of the forearm, about 4 inches below the anticubital area, is the currently accepted standard for determination of infection with M. tuberculosis. The remainder of this article is limited to tuberculin testing using the Mantoux technique, as the multiple puncture test technique results are even less reliable. This is due to the lack of control of antigen deposited in the skin and the method of administration (CDC, 1991b) .
ADMINISTRATION
Practitioners should not be deceived by the apparent simplicity of the test; the tuberculin reaction is a complex immunologic phenomenon. Careful attention should be paid to detail; do not complicate the procedure by using poor technique. • Cleanse the site with 70% alcohol and allow to dry. Usually the flexor or dorsal surface of the forearm, using an area free of lesions and away from veins, is recommended. • The test material is administered with a tuberculin syringe fitted with a short bevel, Ih inch, 26 or 27 gauge lA-B ). Inject the solution being sure to produce a' "wheal"-a discrete, pale elevation of the skin 6 to 10 mm in diameter-with an orange peel appearance ( Figure 2 ). This will disappear in a short time, and no dressing is required. • In the event the injection is delivered subcutaneously (i.e., no wheal is produced), or if a significant part of the dose leaks from the injection site, the test should be repeated immediately at another site at least 5 em (2 inches) from the first site, or in the other arm. Make a note indicating the second test site (ATS/CDC, 1981).
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• Record in the employee's confidential health record: the date the test was administered; the technique used; name, strength, amount, and serial number of the PPD solution; as well as the date read and result in millimeters (mm). A computerized database is necessary for rapid retrieval and periodic analysis of tuberculosis (TB) infection by area and work group in a facility (CDC, 1994) .
IMMUNOLOGIC BASIS FOR THE TUBERCULIN REACTION
The reaction to intracutaneously injected tuberculin is a classic example of a delayed (cellular) hypersensitivity reaction. Characteristic features of the reaction include: delayed course, reaching a peak more than 24 hours after testing; indurated character, largely because of cell infiltration; and occasional vesiculation and necrosis (ATS/CDC, 1981). Characteristically, delayed hypersensitivity reactions to tuberculin begin at 5 to 6 hours, are maximal at 48 to 72 hours, and subside over a period of days. Reactions may develop slowly in a few persons-those who are elderly or those who are being tested for the first time-and may not peak until after 72 hours. Immediate hypersensitivity reactions to tuberculin or its constituents will occur shortly after injection, disappear by 24 hours, and are not likely to be confused with delayed hypersensitivity reactions. A delayed hypersensitivity reaction to tuberculin is nearly always a manifestation of previous infection with M. tuberculosis or a variety of nontuberculous mycobacteria (ATS/ CDC, 1990) .
PPD tests should be read by designated, trained personnel between 48 and 72 hours after injection. However, positive reactions may be measured up to a week after testing (CDC, 1991a) . Self reading of a PPD by a health care worker or other client should not be accepted (CDC, 1994) .
INTERPRETATION OF TUBERCULIN REACTION
Only induration should be considered in interpreting 372 Sub cu taneous Tissue the test. Readings should be made in a good light, with the forearm slightly flexed. The presence or absence of induration should be determined by inspection from a side view against the light as well as by direct light. Another method used to determine induration is palpation; lightly slide the tip of the index finger over the test site feeling for a raised area. Ifa raised area is felt, take a ballpoint pen and very lightly draw a line into the indurated area from each side of the arm. When resistance is felt, stop; then measure the space in millimeters between the two lines ( Figure 3) . The diameter of induration should be measured transversely to the long axis of the forearm and recorded in millimeters (ATS/CDC, 1981). Erythema has no diagnostic value and should be disregarded. In the absence of induration, an area of erythema greater than 10 mm in diameter may indicate the injection was made too deeply and retesting is indicated using another site. Individuals with a positive reaction to a TB skin test have no need for additional tuberculin testing, but should be further evaluated for TB disease and instructed to report promptly any symptoms suggesting TB (i.e., cough, hemoptysis, night sweats, or weight loss).
Positive Reaction
Persons with sensitivity to tuberculin are known as "reactors"; however, not all reactors are infected with M. tuberculosis. Cross reactions commonly occur in many parts of the world . The distinction between reactions that represent TB infection and cross reaction is not precise, but in general the larger the reaction, the greater the probability that the reaction represents infection with M. tuberculosis (ATS/CDC , 1990) . To ensure that few persons infected with M. tuberculosis will be classified as negative reactors and those not infected with M. tuberculosis will not be classified as positive reactors, different cut points are used for different groups, depending on the risk of TB for that group . However, vesiculation is always considered a positive reaction (Table 1) . .15 mm is classified as positive for persons who do not meet any of the above criteria. 4. Recent converters are defined on the basis of both induration and age:
False Positive Reactions
• ;;.10 -mm increase within a 2 year period is classified as positive for persons <35 years of age. • ;;.15 mm increase within a 2 year period is classified as positive for persons > 35 years of age. • ;;.5 mm increases under certain circumstances (No.1 above).
'Recent close contact implies household contact or unprotected occupational exposure similar in intensity and duration to household contact (CDC, 1994) .
is hypersensivity to mycobacteria other than M. tuberculosis. This type of cross reaction tends to be smaller than reactions due to TB infection. Unfortunately, there is no cut point at which a clean separation exists between those infected with M. tuberculosis and those who are not. A reaction of 15 mm is a conservative estimate that a person is infected with M. tuberculosis. It is important to remember that reactions from M. tuberculosis are more likely to be common than a cross reaction in a person whose chest x-ray is consistent with TB, or those who have had close contact with a person with active TB (ATS/CDC, 1981). In some localities in the United States, cross reactions are likely to out number reactions caused by M. tuberculosis. A cut point of 10 mm for adults may prevent mis-classification in this instance. For example, children in the southeastern United States with no history of contact with TB and no clinical contact or positive x-ray findings may need a cut point larger than 10 mm (ATS/CDC,1981).
Negative Reactions
Reactions below the cut point for a positive test result are considered to be a negative (ATS/CDC, JULY 1995, VOL. 43, NO. 7 
1990). A negative or non-significant reaction alone does not exclude a diagnosis of TB from further con sideration.
Individuals with recent exposure may not have yet developed hypersensitivity to mycobacteria (ATS/CDC, 1981) .
False Negative Reaction
Of major concern is an individual having a current TB process and being falsely classified as non-significant. Many conditions that cause a delayed hypersensitivity and therefore cause such a false reaction have been reported (Table 2) (ATS/CDC , 1981) .
If an individual is suspected of being anergic, as could be the case with human immunodeficiency virus (HIV) infection, concurrent anergy testing is indicated. Anergy testing is accomplished with two other delayed type hypersensitivity (DTH) skin test antigens. Anergy testing at the time of initial PPD testing is preferable, due to logistical problems and nonadherance associated with repeat testing and reading.
All skin test responses should be measured at 48 to 72 hours after administration. Any amount of induration, not erythema, is considered evidence to DTH, and not considered anergic. Persons unresponsive to DTH, including PPD, are considered anergic. Persons with a positive DTH response to one or more of the DTH antigens but not to 374 PPD are not considered to be infected withM. tuberculosis. A ;35 mm PPD reaction is considered to be evidence of TB infection, regardless of the reactions to the other antigens (CDC, 1991b) .
The age of the persons being tested may have an effect on their responsiveness to TB testing, as tuberculin reactivity tends to wane with time after infection, and this process seems to accelerate with increasing age as well. However, an individual's ability to respond to PPD testing may be enhanced by repeated testing (booster phenomenon) (ATS/ CDC, 1981) .
BOOSTING TUBERCULIN SENSITIVITY
Some tuberculin reactors' sensitivity to tuberculin will decline over time and their skin test will become negative. The administration of a single tuberculin skin test will itself boost immunologic memory; therefore, a second tuberculin skin test will react as positive Tuberculin Testing Placement and Interpretation. up to 2 years later. Two step skin testing will prevent this individual from being reported as a converter (Barnes, 1993) . Two step testing is indicated on employment if an individual has a negative reaction to the initial TB skin test. A second skin test should be placed within 1 to 4 weeks, and the result of the second test would be considered the base line. Two step testing would no longer be indicated for this individual if they were being followed in a TB surveillance program.
BACILLE CALMETTE-GUERINVACCINATION
A history of Bacille Calmette-Guerin (BCG) vaccination is not a contraindication to PPD skin testing in an adult. Many BCG vaccinated individuals immigrated from areas of the world where TB transmission frequently occurs, and may have been infected following vaccination. The larger the reaction to PPD, the greater the probability of TB infection. Conversion rates after vaccination are usually much less than 100%, and sensitivity often diminishes considerably over a period of years (Snider, 1985) .
CONCLUSION
All individuals without documented evidence of a positive PPD, adequate preventive therapy for infection, or adequate treatment for disease should be tuberculin skin tested (CDC, 1994) .
The interpretation of a tuberculin skin test should be greatly influenced by the purpose for which the test was given and by the consequences of false classification. Because errors in classification cannot be avoided, it is important to minimize them by establishing an appropriate definition of a significant reaction or cut point (ATS/CDC, 1981) .
Every individual should be given a record of their skin test results, chest x-ray, and treatment schedule to prevent retesting when they change employment (ATS/ CDC, 1983) .
Placement and interpretation of the tuberculin skin test should be provided by health practitioners "who are qualified as a result of education and experience. Assistance with knowledge is available from local or state health agencies, the American Lung Association, the Centers for Disease Control and Prevention, local medical libraries, or networking among other experienced professionals.
Recommended as being very useful are a wall chart and video "The Mantoux Tuberculin Skin Test," both available free from the Centers for Disease Control and Prevention (CDC), Division of TB Elimination, Atlanta, Georgia 30333, or by calling (404) 639-3311. 1.
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The Mantoux skin test is the currently accepted standard for determination of infection with Mycobacterium tuberculosis. It is less than 100% sensitive and specific; however, no better method currently exists.
Placement and interpretation of the tuberculin skin test should be provided by health practitioners who are qualified as a result of education and experience. Always produce a "wheal" when administering a tuberculosis (TB) skin test. If a significant amount of the dose leaks from the injection site or the injection is administered subcutaneously, the test should be repeated immediately at another site.
Induration, not erythema, should be considered in interpreting the TB skin test. The absence of induration with erythema greater than 10 mm in diameter may indicate the injection was made too deeply and retesting is indicated.
A history of BCG vaccination is not a contraindication to PPD skin testing. The larger the reaction to PPD, the greater the probability of TB infection.
